TITLE

Immunogenicity of recombinant BCG vaccine strains overexpressing components of the antigen 85 complex of Mycobacterium tuberculosis

AUTHOR(S)
Dhar, Neeraj; Rao, Vivek; Tyagi, Anil K.
PUB. DATE
February 2004
SOURCE
Medical Microbiology & Immunology;Feb2004, Vol. 193 Issue 1, p19
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The components of antigen 85 complex of Mycobacterium tuberculosis (Ag 85A, Ag 85B and Ag 85C), due to their immunodominant and secretory nature, represent promising protective antigen candidates and have been used in numerous vaccine preparations. We have used recombinant Bacille Calmette Guerin (BCG) strains overexpressing Ag 85A and Ag 85C to immunize BALB/c mice to investigate the immunogenicity of these strains. Mice immunized with recombinant BCG strains exhibited an increased humoral immune response when compared to mice immunized with wild-type BCG. The recombinant BCG strain overexpressing Ag 85A also induced an increased Th1-like response, characterized by elevated levels of IFN-γ in antigen stimulated splenocyte cultures and a strong IgG2a antibody response, when compared to wild-type BCG. Immunization with recombinant BCG strain overexpressing Ag 85C, on the other hand did not elicit increased IFN-γ secretion on restimulation of splenocytes in vitro.
ACCESSION #
17040547

 

Related Articles

  • Immunological evaluation of a novel Mycobacterium tuberculosis antigen, Rv3117, absent in Mycobacterium bovis BCG. JUNWEI ZHAO; ZHANQIANG SUN; HAO PEI; JUAN YE; CUICUI CHEN; BUKA SAMTEN; SHULIN ZHANG; XIAOKUI GUO // Molecular Medicine Reports;2013, Vol. 8 Issue 5, p1587 

    Tuberculosis (TB) remains a global infectious disease. To investigate the value of a novel Mycobacterium tuberculosis (M. tuberculosis) region of difference 5 (RD5) encoded antigen, Rv3117, in the development of effective immunodiagnostics and vaccines against TB, the immune responses to the...

  • Innovative strategies to identify M. tuberculosis antigens and epitopes using genome-wide analyses. Geluk, Annemieke; van Meijgaarden, Krista E.; Joosten, Simone A.; Commandeur, Susanna; Ottenhoff, Tom H. M. // Frontiers in Immunology;Jun2014, Vol. 5, p1 

    In view of the fact that only a small part of the Mtb expressome has been explored for identification of antigens capable of activating human T-cell responses, which is critically required for the design of better TB vaccination strategies, more emphasis should be placed on innovative ways to...

  • HUMORAL AND CELL-MEDIATED IMMUNE RESPONSES IN FOETAL SHEEP FOLLOWING VACCINATION WITH BCG. Fahey, Kevin J. // Australian Journal of Experimental Biology & Medical Science;Aug1977, Vol. 55 Issue 4, p419 

    This article cites a study investigating humoral and cell-mediated immune responses in foetal sheep following vaccination with Bacille Calmette-Guerin (BCG) vaccines. It has been stated on several occasions that foetal sheep do not produce haemagglutinating antibody when injected with viable...

  • A live attenuated BCG vaccine overexpressing multistage antigens Ag85B and HspX provides superior protection against Mycobacterium tuberculosis infection. Yuan, Xuefeng; Teng, Xindong; Jing, Yukai; Ma, Jilei; Tian, Maopeng; Yu, Qi; Zhou, Lei; Wang, Ruibo; Wang, Weihua; Li, Li; Fan, Xionglin // Applied Microbiology & Biotechnology;Dec2015, Vol. 99 Issue 24, p10587 

    Tuberculosis (TB) remains one of the most menacing infectious diseases, although attenuated Mycobacterium bovis Bacillus Calmette-Guerin (BCG) vaccine has been widely used to protect children against primary TB. There are increasing evidences that rapid growing and dormant Mycobacterium...

  • Comprehensive definition of human immunodominant CD8 antigens in tuberculosis. Lewinsohn, Deborah A.; Swarbrick, Gwendolyn M.; Park, Byung; Cansler, Meghan E.; Null, Megan D.; Toren, Katelynne G.; Baseke, Joy; Zalwango, Sarah; Mayanja-Kizza, Harriet; Malone, LaShaunda L.; Nyendak, Melissa; Wu, Guanming; Guinn, Kristi; McWeeney, Shannon; Mori, Tomi; Chervenak, Keith A.; Sherman, David R.; Boom, W. Henry; Lewinsohn, David M. // NPJ Vaccines;2017, Vol. 2 Issue 1, pN.PAG 

    Despite widespread use of the Bacillus Calmette-Guerin vaccine, tuberculosis, caused by infection with Mycobacterium tuberculosis, remains a leading cause of morbidity and mortality worldwide. As CD8+ T cells are critical to tuberculosis host defense and a phase 2b vaccine trial of modified...

  • T-cell and serological responses to Erp, an exported Mycobacterium tuberculosis protein, in tuberculosis patients and healthy individuals. Martinez, Valérie; Carcelain, Guislaine; Badell, Edgar; Jouan, Marc; Mauger, Isabelle; Sellier, Pierre; Truffot, Chantal; Bricaire, François; Arend, Sandra M.; Ottenhoff, Tom; Autran, Brigitte; Gicquel, Brigitte // BMC Infectious Diseases;2007, Vol. 7 Issue 1, p1 

    Background: The identification of antigens able to differentiate tuberculosis (TB) disease from TB infection would be valuable. Cellular and humoral immune responses to Erp (Exported repetitive protein) - a recently identified M. tuberculosis protein - have not yet been investigated in humans...

  • The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. Lin, Philana Ling; Dietrich, Jes; Tan, Esterlina; Abalos, Rodolfo M.; Burgos, Jasmin; Bigbee, Carolyn; Bigbee, Matthew; Milk, Leslie; Gideon, Hannah P.; Rodgers, Mark; Cochran, Catherine; Guinn, Kristi M.; Sherman, David R.; Klein, Edwin; Janssen, Christopher; Flynn, JoAnne L.; Andersen, Peter // Journal of Clinical Investigation;Jan2012, Vol. 122 Issue 1, p303 

    It is estimated that one-third of the world's population is infected with Mycobacterium tuberculosis. Infection typically remains latent, but it can reactivate to cause clinical disease. The only vaccine, Mycobacterium bovis bacillus Calmette-Guérin (BCG), is largely ineffective, and ways to...

  • La inmunidad antituberculosa y su aplicación en el desarrollo de candidatos vacunales. García, María de los Ángeles; Sarmiento, María Elena; Acosta, Armando // Revista VacciMonitor (Vacunología y Temas Afines);Jan-Abr2009, Vol. 18 Issue 1, p25 

    The incidence of tuberculosis has reached alarming rates nowadays. BCG vaccine, the only anti-tuberculosis vaccine available has been inefficient in several field trials around the world. It is currently imperative to obtain new vaccines against tuberculosis. A better understanding of the immune...

  • Immune Response to Postprimary Tuberculosis in Mice: Mycobacterium tuberculosis and Miycobacterium bovis bacille Calmette-Guérin Induce Equal Protection. Mollenkopf, Hans-Joachim; Kursar, Mischo; Kaufmann, Stefan H.E. // Journal of Infectious Diseases;8/1/2004, Vol. 190 Issue 3, p588 

    We addressed the question of whether protective immunity induced by natural infection with Mycobacterium tuberculosis and that induced by vaccination with Mycobacterium bovis bacille Calmette-Guérin (BCG) differ in the murine model. We infected mice with M. tuberculosis Erdman, cured them by...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics